Key terms

About FENC

Fennec Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development of sodium thiosulfate for the prevention of ototoxicity from cisplatin in pediatric cancer patients. The company was founded by Orest W. Blaschuk on September 3, 1996 and is headquartered in Durham, NC.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest FENC news

Apr 04 6:26am ET Buy Rating Reaffirmed for Fennec Pharmaceuticals Following Strategic European Licensing Deal and Strong Financial Outlook by TipRanks Apr 04 6:11am ET Fennec price target raised to $18 from $17 at H.C. Wainwright by TipRanks Apr 01 2:37pm ET Fennec Pharmaceuticals Reports Strong 2023 Growth by TipRanks Mar 29 7:35am ET Fennec Pharmaceuticals: A Strong Buy on PEDMARK’s Success and Expansion Potential by TipRanks Mar 27 11:25am ET Fennec participates in a conference call with Craig-Hallum by TipRanks Mar 27 4:55am ET Fennec participates in a conference call with Craig-Hallum by TipRanks Mar 22 1:50pm ET Fennec participates in a conference call with Craig-Hallum by TipRanks Mar 22 9:38am ET Fennec price target raised to $20 from $18 at Craig-Hallum by TipRanks Mar 21 8:45pm ET Buy Rating for Fennec Pharmaceuticals Amidst Strong Pedmark Sales and Market Expansion Potential by TipRanks Mar 21 7:37pm ET Fennec Pharmaceuticals Files SEC 8-K Report by TipRanks Mar 21 6:37am ET Fennec Pharmaceuticals’ Soaring Sales and New Deal by TipRanks Mar 21 6:03am ET Fennec reports Q4 EPS (10c), consensus (2c) by TipRanks Mar 18 3:05pm ET Fennec price target raised to $18 from $17 at Craig-Hallum by TipRanks Mar 18 12:35pm ET Capital One Financial Sticks to Their Buy Rating for Fennec Pharmaceuticals (FENC) by TipRanks Mar 17 9:37pm ET Fennec Pharmaceuticals Strikes Major European Deal by TipRanks Feb 29 12:25pm ET Buy Rating for Fennec Pharmaceuticals Amid Strong Pedmark Sales and Market Expansion Potential by TipRanks Feb 29 9:25am ET Fennec Pharmaceuticals (FENC) Gets a Buy from Craig-Hallum by TipRanks Feb 29 7:16am ET Fennec sees FY23 revenue $20.7M-$21.2M, consensus $19.57M by TipRanks Feb 29 7:16am ET Fennec sees Q4 revenue $9.2M-$9.7M, consensus $8.06M by TipRanks Feb 01 9:10am ET Analysts Offer Insights on Healthcare Companies: Fennec Pharmaceuticals (FENC) and Societal CDMO (SCTL) by TipRanks

No recent press releases are available for FENC

FENC Financials

1-year income & revenue

Key terms

FENC Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

FENC Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

People walk past the New York Stock Exchange (NYSE) on March 28, 2024 in New York City.
NDZ/STAR MAX/IPx/AP
What stalled this year’s seemingly infallible stock market rally
A working oil pumpjack is pictured in Taft, Kern County, California on September 21, 2023.
Frederic J. Brown/AFP/Getty Images
Oil prices get short-lived boost from attack on Iran
NEW YORK, NEW YORK - FEBRUARY 08: A New York Community Bank stands in Brooklyn on February 08, 2024 in New York City. New York Community Bancorp, a regional lender, shed about 60% of its value over the past eight days and its credit rating has been downgraded to Junk by Moody's. (Photo by Spencer Platt/Getty Images)
Spencer Platt/Getty Images
US regional banks are still under pressure. That’s likely to continue
Trump Media, which runs the social media platform Truth Social, took the place of Digital World's place on the Nasdaq stock exchange in March.
Frank Franklin II/AP
Trump Media stock ends session 15% higher after two very bad days